Ablation of Venous Malformations by Photothermal Therapy with Intravenous Gold Nanoshells.

enhanced permeation retention gold nanoshells photothermal therapy vascular anomalies venous malformations

Journal

Nano letters
ISSN: 1530-6992
Titre abrégé: Nano Lett
Pays: United States
ID NLM: 101088070

Informations de publication

Date de publication:
09 08 2023
Historique:
medline: 10 8 2023
pubmed: 27 7 2023
entrez: 27 7 2023
Statut: ppublish

Résumé

Venous malformations (VMs) consist of hugely enlarged and dysmorphic veins. These lesions cause significant disfigurement, pain, and complications such as bleeding and coagulopathy. Pharmacotherapy for the treatment of VMs has limited efficacy and potentially limiting toxicity. Current treatment for patients with VMs entails life-long pharmacotherapy or surgical procedures. Here we explored whether intravenously administered agents can be used to destroy VMs by photothermal therapy (PTT), using gold nanoshells (AuNSs) that generated heat following irradiation with near-infrared (NIR) light. In a murine model of VMs, intravenous AuNSs accumulated within the VMs. Irradiation of the VMs induced marked regression and even elimination. Nanoparticle-based photothermal therapy can provide effective therapy for VMs, which are otherwise relatively refractory to treatment.

Identifiants

pubmed: 37498114
doi: 10.1021/acs.nanolett.3c01945
doi:

Substances chimiques

Gold 7440-57-5

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7092-7099

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL117952
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM131728
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL153782
Pays : United States

Auteurs

Kathleen Cullion (K)

Laboratory for Biomaterials and Drug Delivery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.
Department of Medical Critical Care, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.

Claire A Ostertag-Hill (CA)

Laboratory for Biomaterials and Drug Delivery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.
Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.

Michelle Pan (M)

Laboratory for Biomaterials and Drug Delivery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.
Department of Medical Critical Care, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.

Brian Timko (B)

Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States.

Elisa Boscolo (E)

Division of Experiment Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, Ohio 45229, United States.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229, United States.

Daniel S Kohane (DS)

Laboratory for Biomaterials and Drug Delivery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.
Department of Anesthesiology, Critical Care, and Pain Management, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH